✦ LIBER ✦

Proteomic approaches to biomarker discovery in prostate and bladder cancers

✍ Scribed by Bao-Ling Adam; Antonia Vlahou; Oliver John Semmes; George L. Wright; Jr.

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 89 KB
Volume: 1
Category: Article
ISSN: 1615-9853
DOI: 10.1002/1615-9861(200110)1:10<1264::aid-prot1264>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Global proteomics and metabolomics in ca

Global proteomics and metabolomics in cancer biomarker discovery

✍ Haleem J. Issaq; Stephen D. Fox; King C. Chan; Timothy D. Veenstra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract Chromatography and electrophoresis have been used for the last half‐century to separate small and large molecules. Advances in MS instrumentation and techniques for sample introduction into the mass analyzer (i.e. matrix‐assisted laser desorption/ionization and electrospray ionization),

New proteomic approaches for biomarker d

New proteomic approaches for biomarker discovery in inflammatory bowel disease

✍ Giulia Roda; Alessandra Caponi; Marco Benevento; Paolo Nanni; Laura Mezzanotte; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

There is an increasing interest in the discovery of new inflammatory bowel disease (IBD) biomarkers able to predict the future patterns of disease and to help in diagnosis, treatment, and prognosis. A biomarker is a substance that can be measured biologically and is associated with an increased risk

Biomarker discovery in lung cancer—promi

Biomarker discovery in lung cancer—promises and challenges of clinical proteomics

✍ Ajit Bharti; Patrick C. Ma; Ravi Salgia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

## Abstract Lung cancer is a devastating illness with an overall poor prognosis. To effectively address this disease, early detection and novel therapeutics are required. Early detection of lung cancer is challenging, in part because of the lack of adequate tumor biomarkers. The goal of this review

Cancer proteomics and its application to

Cancer proteomics and its application to discovery of therapy response markers in human cancer

✍ Laura Smith; Michael J. Lind; Kevin J. Welham; Lynn Cawkwell; Cancer Biology Pro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract The administration of chemotherapy either alone or in combination with radiotherapy is an important factor in reducing the mortality and morbidity of cancer patients. Resistance to both chemotherapy and radiotherapy represents a major obstacle to a successful outcome. The identification

Screening, risk assessment, and the appr

Screening, risk assessment, and the approach to therapy in patients with prostate cancer

✍ Stephen J. Freedland 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 1 views

New basic discoveries and frontiers in d

New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors

✍ Giovan Giacomo Giordano; Elda Tagliabue; Serenella M. Pupa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

## Abstract The fourth edition of this workshop mainly focused on three different human oncotypes, which included thyroid, urinary bladder, and prostate tumors as clinical models to gain new basic knowledge on tumor diagnosis, prognosis, and treatment. At the previous editions (Giordano et al., 200